- Home
- GNS vs LGVN Comparison
GNS vs LGVN Comparison
Compare GNS & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNS
- LGVN
- Stock Information
- Founded
- GNS 2002
- LGVN 2014
- Country
- GNS Singapore
- LGVN United States
- Employees
- GNS N/A
- LGVN N/A
- Industry
- GNS Other Consumer Services
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- GNS Real Estate
- LGVN Health Care
- Exchange
- GNS Nasdaq
- LGVN Nasdaq
- Market Cap
- GNS 23.4M
- LGVN 27.6M
- IPO Year
- GNS 2022
- LGVN 2021
- Fundamental
- Price
- GNS $0.25
- LGVN $1.56
- Analyst Decision
- GNS
- LGVN Strong Buy
- Analyst Count
- GNS 0
- LGVN 3
- Target Price
- GNS N/A
- LGVN $8.67
- AVG Volume (30 Days)
- GNS 1.6M
- LGVN 201.8K
- Earning Date
- GNS 05-14-2025
- LGVN 05-13-2025
- Dividend Yield
- GNS N/A
- LGVN N/A
- EPS Growth
- GNS N/A
- LGVN N/A
- EPS
- GNS N/A
- LGVN N/A
- Revenue
- GNS $16,147,348.00
- LGVN $2,392,000.00
- Revenue This Year
- GNS N/A
- LGVN $26.05
- Revenue Next Year
- GNS $47.43
- LGVN $12.27
- P/E Ratio
- GNS N/A
- LGVN N/A
- Revenue Growth
- GNS N/A
- LGVN 237.38
- 52 Week Low
- GNS $0.21
- LGVN $0.77
- 52 Week High
- GNS $5.69
- LGVN $6.40
- Technical
- Relative Strength Index (RSI)
- GNS 38.79
- LGVN 45.61
- Support Level
- GNS $0.21
- LGVN $1.44
- Resistance Level
- GNS $0.33
- LGVN $1.62
- Average True Range (ATR)
- GNS 0.04
- LGVN 0.12
- MACD
- GNS -0.00
- LGVN -0.02
- Stochastic Oscillator
- GNS 30.36
- LGVN 25.00
About GNS Genius Group Limited
Genius Group Ltd is an Edtech and education company that provides entrepreneur education system business development tools and management consultancy services to entrepreneurs and entrepreneur resorts. The company's business consists of two reportable business segments: Education - entrepreneur education, management consultancy, and business development tools; and Campus - resorts, retreats, and co-working cafes for entrepreneurs. It derives the majority of its revenue from the Education segment.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.